These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23156253)

  • 61. [Mechanism of metastasis in cervical cancer].
    Kodama J; Hiramatsu Y
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():100-3. PubMed ID: 23156225
    [No Abstract]   [Full Text] [Related]  

  • 62. The role of immunotherapy in recurrent or metastatic cervical cancer.
    Randall LM
    Clin Adv Hematol Oncol; 2022 Jul; 20(7):435-437. PubMed ID: 35802874
    [No Abstract]   [Full Text] [Related]  

  • 63. Can recurrent cervical carcinoma be successfully managed?
    Munnell EW
    JAMA; 1965 Oct; 194(3):275. PubMed ID: 5897341
    [No Abstract]   [Full Text] [Related]  

  • 64. Cancer of the cervix, stage IV and recurrent carcinoma. Comment.
    Rubin P
    JAMA; 1965 Oct; 194(3):278. PubMed ID: 5897343
    [No Abstract]   [Full Text] [Related]  

  • 65. [Research progress of the transition probabilities of the natural history model of cervical cancer].
    Ci PW; Wang LH; Zhao FH; Yang J; Qiao YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Dec; 32(12):1292-5. PubMed ID: 22336620
    [No Abstract]   [Full Text] [Related]  

  • 66. Adoptive T-cell therapy is a promising salvage approach for advanced or recurrent metastatic cervical cancer.
    Zsiros E; Tsuji T; Odunsi K
    J Clin Oncol; 2015 May; 33(14):1521-2. PubMed ID: 25847926
    [No Abstract]   [Full Text] [Related]  

  • 67. Resuscitation or not?
    Davies CM; Paul P; Closs SP
    Palliat Med; 2002 Nov; 16(6):549. PubMed ID: 12465708
    [No Abstract]   [Full Text] [Related]  

  • 68. Future Perspectives for Uterine Cervical Cancer Treatment based on Integrative Genomic and Molecular Characterizations.
    Tiezzi DG
    Rev Bras Ginecol Obstet; 2017 Apr; 39(4):147-148. PubMed ID: 28351082
    [No Abstract]   [Full Text] [Related]  

  • 69. [Therapy of recurrent cervical cancer].
    Sekiba K; Hayase R
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1839-42. PubMed ID: 2393303
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pushing the bar in treatment of cervical cancer: what can comprehensive cancer centers do on their own?
    Dizon DS; Ambrosio AJ; Feltmate C; Wright AA; Campos SM; Viswanathan A;
    Gynecol Oncol; 2013 Nov; 131(2):464-6. PubMed ID: 23938373
    [No Abstract]   [Full Text] [Related]  

  • 71. [Treatment of stage I and II uterine cervix cancer. Round table].
    Dargent D; Durand JC; Michel G; Pourquier H; Rudigoz RC; Senèze J
    Rev Fr Gynecol Obstet; 1985 Apr; 80(5):299-322. PubMed ID: 4023538
    [No Abstract]   [Full Text] [Related]  

  • 72. [Treatment of recurrent cervical cancer].
    Takamizawa H; Kasai T; Arai T
    Gan No Rinsho; 1983 Aug; 29(10):1079-84. PubMed ID: 6632194
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Treatment of recurrent cervical cancer].
    Aihara S; Iwasaka T
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():260-4. PubMed ID: 23156253
    [No Abstract]   [Full Text] [Related]  

  • 74. The diagnosis and treatment of early (preclinical) invasive cervical cancer.
    Coppleson M
    Clin Obstet Gynaecol; 1985 Mar; 12(1):149-68. PubMed ID: 3888481
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.